First off Label Endovascular Clinical Experience to Treat Diffuse Cerebral Venous Sinus Thrombosis Using the INARI FlowTriever System: Case Report

Saif Bushnaq; Samer Abdul Kareem; Nicholas Liaw; Bader Alenzi; Muhammad Khaleeq Ahmed; Merna Bushnaq; Osama O Zaidat

doi:10.3389/fneur.2021.778842

First off Label Endovascular Clinical Experience to Treat Diffuse Cerebral Venous Sinus Thrombosis Using the INARI FlowTriever System: Case Report

Front Neurol. 2021 Dec 17:12:778842. doi: 10.3389/fneur.2021.778842. eCollection 2021.

Authors

Saif Bushnaq¹, Samer Abdul Kareem², Nicholas Liaw², Bader Alenzi², Muhammad Khaleeq Ahmed³, Merna Bushnaq⁴, Osama O Zaidat²

Affiliations

¹ Texas Tech University Health Sciences Center, Lubbock, TX, United States.
² St Vincent Mercy Hospital, Neuroscience Institute, Toledo, OH, United States.
³ Medical College of Georgia, Augusta, GA, United States.
⁴ King Hussein Cancer Center, Amman, Jordan.

Abstract

Anticoagulation with heparin is the current mainstay treatment for Cerebral Venous Sinus Thrombosis (CVST). Endovascular treatment is increasingly being used to treat patients with CVST who are non-responsive to anticoagulation. These more aggressive interventions include catheter-based local chemical thrombolysis, balloon angioplasty and mechanical thrombectomy with uncertain safety and efficacy. Here we describe the first reported clinical experience using the INARI FlowTriever system to treat a patient presented with focal weakness and found to have diffuse CVST.

Keywords: INARI FlowTriever system; case report; cerebral venous sinus thrombosis; endovascular treatment; intervention.

Publication types

Case Reports